ArticleLeukemia2013

Phase I study of ON 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed/refractory B-cell malignancies.

M Roschewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.